Submissions

Login or Register to make a submission.

To submit a new paper to our journal:

  1. Register on the Journal website; we encourage you to register also as a Reviewer at the same time;
  2. Download and follow the Guidelines for Authors;
  3. Read our Editorial Policies and our Competing Interest policies.
  4. Log in;
  5. Click on the "MAKE A SUBMISSION" button to start the online procedure.

To submit a revised version:

  1. Log in;
  2. Click on the title of your paper;
  3. Next to the heading "REVISIONS", upload your revised paper by using the "UPLOAD FILE" button;
  4. Inform the Editors that a revised version has been uploaded.

Guidelines for Authors

Manuscripts should be uploaded as Word (.doc) or Rich Text Format (.rft) files (not write-protected) plus separate figure files: TIF, EPS, JPEG files are acceptable for submission. The text file must contain the abstract, main text, references, tables and figure legends, but no embedded figures or title page. The title page should be provided as a separate file. In the main text, please reference figures as for instance figure 1, figure 2 etc to match the tag name you choose for the individual figure files uploaded. Please note that manuscripts must be written in English. Authors whose native language is not English are strongly advised to have their manuscript checked by a language editing service or by a native English speaker prior to submission.

As an option, PAGEPress offers its own professional copyediting service. Professional copyediting can help authors improve the presentation of their work and increase its chances of being taken on by a publisher. In case you feel that your manuscript needs a professional English language copyediting checking language grammar and style, you can find a reliable revision service at:

Manuscript Types Accepted

Original Scientific Articles: must describe significant and original experimental observations and provide sufficient detail so that the observations can be critically evaluated and, if necessary, repeated. Original Scientific Articles must conform to the highest international standards in the field.
Review Articles: are accepted for their broad general interest; all are refereed by experts in the field who are asked to comment on issues such as timeliness, general interest and balanced treatment of controversies, as well as on scientific accuracy. Reviews should generally include a clearly defined search strategy and take a broad view of the field rather than merely summarizing the authors' own previous work. Extensive or unbalanced citation of the authors' own publications is discouraged.
Mini Review Articles: are accepted to address current evidence on well-defined clinical, research or methodological topics. All are refereed by experts in the field who are asked to comment on timeliness, general interest, balanced treatment of controversies, and scientific rigor. A clear research question, search strategy and balanced synthesis of the evidence is expected. Manuscripts are limited in terms of word-length and number of figures.
Clinical Articles: are suited to describe significant improvements in clinical practice such as the report of a novel technique, a breakthrough in technology or practical approaches to recognised clinical challenges. They should conform to the highest scientific and clinical practice standards.
Case Reports or Case Series: illustrating unusual and clinically relevant observations are acceptable, but they must be of sufficiently high quality to be considered worthy of publication in the Journal. On rare occasions, completed cases displaying nonobvious solutions to significant clinical challenges will be considered. Illustrative material must be of the highest quality and healing outcomes, if appropriate, should be demonstrated.

Manuscript Format

The official language of the publication is English. It is preferred that manuscript is professionally edited. All services are paid for and arranged by the author and use of one of these services does not guarantee acceptance or preference for publication.

Authors should pay special attention to the presentation of their research findings or clinical reports so that they may be communicated clearly. Technical jargon should be avoided as much as possible and clearly explained where its use is unavoidable. Abbreviations should also be kept to a minimum, particularly those that are not standard. Giornale Italiano di Endodonzia adheres to the conventions outlined in Units, Symbols and Abbreviations: A Guide for Medical and Scientific Editors and Authors. When non-standard terms appearing three or more times in the manuscript are to be abbreviated, they should be written out completely in the text when first used with the abbreviation in parenthesis. If abbreviations are used in the text, authors are required to write full name+abbreviation in brackets [e.g. Multiple Myeloma (MM)] the first time they are used, then only abbreviations can be written (apart from titles; in this case authors have to write always the full name).

If names of equipment or substances are mentioned in the text, brand, company names and locations (city and state) for equipment and substances should be included in parentheses within the text.

The background and hypotheses underlying the study, as well as its main conclusions, should be clearly explained. Titles and abstracts especially should be written in language that will be readily intelligible to any scientist.

Structure

All manuscripts submitted to Giornale Italiano di Endodonzia should include Title Page, Abstract, Main Text, References and Acknowledgements, Tables, Figures and Figure Legends as appropriate.
Title Page: The title page should bear:

  1. Title, which should be concise as well as descriptive (no more than 150 letters and spaces);
  2. Initial(s) and last (family) name of each author;
  3. Name and address of department, hospital or institution to which the work should be attributed;
  4. Running title (no more than 30 letters and spaces);
  5. Three to five key words (in alphabetical order);
  6. Name, full postal address, telephone, fax number and e-mail address of author responsible for correspondence (Corresponding Author).

Abstracts should be no more than 250 words giving details of what was done: please choose
Abstract for Original Scientific Articles should be no more than 250 words giving details of what was done using the following structure:

  • Aim: give a clear statement of the main aim of the study and the main hypothesis tested, if any;
  • Methodology: describe the methods adopted including, as appropriate, the design of the study, the setting, entry requirements for subjects, use of materials, outcome measures and statistical tests
  • Results: give the main results of the study, including the outcome of any statistical analysis;
  • Conclusions: state the primary conclusions of the study and their implications. Suggest areas for further research, if appropriate. Abstract for Review Articles should be non-structured of no more than 250 words giving details of what was done including the literature search strategy.

Abstract for Mini Review Articles should be non-structured of no more than 250 words, including a clear research question, details of the literature search strategy and clear conclusions.
Abstract for Case Reports and Case Series should be no more than 250 words using the following structure:

  • Aim: give a clear statement of the main aim of the report and the clinical problem which is addressed;
  • Summary: describe the methods adopted including, as appropriate, the design of the study, the setting, entry requirements for subjects, use of materials, outcome measures and analysis if any;
  • Key learning points: provide up to five short, bullet-pointed statements to highlight the key messages of the report. All points must be fully justified by material presented in the report.

Abstract for Clinical Articles should be no more than 250 words using the following structure:

  • Aim: give a clear statement of the main aim of the report and the clinical problem which is addressed;
  • Methodology: describe the methods adopted;
  • Results: give the main results of the study;
  • Conclusions: state the primary conclusions of the study. Main Text of Original Scientific Article should include Introduction, Materials and Methods, Results, Discussion and Conclusion.

The structure of the main text for original scientific articles

Introduction: should be focused, outlining the historical or logical origins of the study and gaps in knowledge. Exhaustive literature reviews are not appropriate. It should close with the explicit statement of the specific aims of the investigation, or hypothesis to be tested.

Material and Methods: must contain sufficient detail such that, in combination with the references cited, all clinical trials and experiments reported can be fully reproduced.

(I) Clinical Trials: should be reported using the CONSORT guidelines available at www.consort-statement.org. A CONSORT checklist and flow diagram (as a Figure) should also be included in the submission material.

(II) Experimental Subjects: experimentation involving human subjects will only be published if such research has been conducted in full accordance with ethical principles, including the World Medical Association Declaration of Helsinki (version 2008) and the additional requirements, if any, of the country where the research has been carried out. Manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and written consent of each subject and according to the above mentioned principles. A statement regarding the fact that the study has been independently reviewed and approved by an ethical board should also be included. Editors reserve the right to reject papers if there are doubts as to whether appropriate procedures have been used. When experimental animals are used the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the Guidelines laid down by the National Institute of Health (NIH) in the USA regarding the care and use of animals for experimental procedures or with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and in accordance with local laws and regulations. All studies using human or animal subjects should include an explicit statement in the Material and Methods section identifying the review and ethics committee approval for each study, if applicable. Editors reserve the right to reject papers if there is doubt as to whether appropriate procedures have been used.

(III) Suppliers: of materials should be named and their location (Company, town/city, state, country) included.

Results: should present the observations with minimal reference to earlier literature or to possible interpretations. Data should not be duplicated in Tables and Figures.

Discussion: may usefully start with a brief summary of the major findings, but repetition of parts of the abstract or of the results section should be avoided. The Discussion section should progress with a review of the methodology before discussing the results in light of previous work in the field. The Discussion should end with a brief conclusion and a comment on the potential clinical relevance of the findings. Statements and interpretation of the data should be appropriately supported by original references.

Conclusion: should contain a summary of the findings.

Main Text of Review Articles should be divided into Introduction, Review and Conclusions.

Main Text of Clinical Reports and Clinical Articles should be divided into Introduction, Report, Discussion and Conclusion. They should be well illustrated with clinical images, radiographs, diagrams and, where appropriate, supporting tables and graphs. However, all illustrations must be of the highest quality.

The Introduction section should be focused to place the subject matter in context and to justify the need for the review.

The Review section should be divided into logical subsections in order to improve readability and enhance understanding. Search strategies must be described and the use of state-of-the-art evidence-based systematic approaches is expected. The use of tabulated and illustrative material is encouraged.

The Conclusion section should reach clear conclusions and/or recommendations on the basis of the evidence presented.

Main Text of Mini Review Articles should be divided into Introduction, Review and Conclusions; please note that the Conclusions section should present clear statements/recommendations and suggestions for further work. The manuscript, including references and figure legends, should not normally exceed 4,000 words.

Main Text of Case Reports and Clinical Articles should be divided into Introduction, Report, Discussion and Conclusion. They should be well illustrated with clinical images, radiographs, diagrams and, where appropriate, supporting tables and graphs. However, all illustrations must be of the highest quality.

Important to know

Manuscript that do not conform to the general aims and scope of the Journal will be returned immediately without review. All other manuscripts will be reviewed by experts in the field (generally two referees). Giornale Italiano di Endodonzia aims to forward referees' comments and to inform the corresponding author of the result of the review process. Manuscripts will be considered for fast-track publication under special circumstances after consultation with the Editor. Giornale Italiano di Endodonzia uses double blinded review which menas that the names of the reviewers will thus not be disclosed to the author submitting a paper and the name(s) of the author(s) will not be disclosed to the reviewers. To allow double blinded review, please submit your main manuscript and title page as separate files.

Acknowledgements: Giornale Italiano di Endodonzia requires that all sources of institutional, private and corporate financial support for the work within the manuscript must be fully acknowledged, and any potential conflicts of interest noted. Grant or contribution numbers may be acknowledged, and principal grant holders should be listed. Acknowledgments should be brief and should not include thanks to anonymous referees and editors.

References: It is the policy of the Journal to encourage reference to the original papers rather than to literature reviews. Authors should therefore keep citations of reviews to the absolute minimum. References should be prepared according to the Vancouver style. References must be numbered consecutively in the order in which they are first cited in the text (not alphabetical order), and they must be identified in the text by Arabic numerals in brackets [example (34)]. References to personal communications and unpublished data should be incorporated in the text and not placed under the numbered references [Example: (Wright 2011, unpublished data) or (Wright 2011, personal communication)]. Where available, URLs for the references should be provided directly within the MS-Word document.

References

References in the References section must be prepared as follows:

  1. more than three authors cite 3 authors et al. If the paper has only 4 authors, cite all authors; e.g. Prati G, Lotti M, Russo F et al.
  2. title style: please use a capital letter only for the first word of the title;
  3. journal titles mentioned in the References list should be abbreviated according to the following websites:
    1. ISI Journal Abbreviations Index (https://www.library.caltech.edu/journal-title-abbreviations);
    2. Biological Journals and Abbreviations (http://home.ncifcrf.gov/research/bja);
    3. Medline List of Journal Titles (https://www.nlm.nih.gov/bsd/serfile_addedinfo.html);
  4. put year after the journal name;
  5. never put month and day in the last part of the references;
  6. cite only the volume (not the issue in brackets);
  7. pages have to be abbreviated, e.g. 351-8.

We recommend the use of a tool such as EndNote or Reference Manager for reference management and formatting. EndNote reference styles can be searched for here: www.endnote.com/support/ enstyles.asp. To ensure the correct citation format, please check your references in the PubMed database (http://www.ncbi.nlm.nih.gov/pubmed).
Examples of correct forms of reference follow.

Standard journal article
(1) Somma F, Cammarota G, Plotino G, Grande NM, Pameijer CH. The effectiveness of manual and mechanical instrumentation for the retreatment of three different root canal filling materials. J Endod 2008;34:466-9.

Corporate author
British Endodontic Society - Guidelines for root canal treatment. Giornale Italiano di Endodonzia 1979;16:192-5.

Journal supplement
Frumin AM, Nussbaum J, Esposito M () Functional asplenia: demonstration of splenic activity by bone marrow scan (Abstract). Blood 1979;54 (Suppl. 1):26a.

Books and other monographs

Personal author(s)
Gutmann J, Harrison JW Surgical Endodontics, 1st edn Boston, MA, USA: Blackwell Scientific Publications, 1991.

Chapter in a book
Wesselink P Conventional rootcanal therapy III: root filling. In: Harty FJ, ed. Endodontics in Clinical Practice, (1990), 3rd edn; pp. 186-223. London, UK: Butterworth.

Published proceedings paper
DuPont B Bone marrow transplantation in severe combined immunodeficiency with an unrelated MLC compatible donor. In: White HJ, Smith R, eds. Proceedings of the Third Annual Meeting of the International Society for Experimental Rematology; (1974), pp. 44-46. Houston, TX, USA: International Society for Experimental Hematology.

Agency publication
Ranofsky AL Surgical Operations in Short-Stay Hospitals: United States-1975 (1978). DHEW publication no. (PHS) 78-1785 (Vital and Health Statistics; Series 13; no. 34.) Hyattsville, MD, USA: National Centre for Health Statistics.

Dissertation or thesis
Saunders EM In vitro and in vivo investigations into root-canal obturation using thermally softened gutta-percha techniques (PhD Thesis) (1988). Dundee, UK: University of Dundee.

URLs
Full reference details must be given along with the URL, i.e. authorship, year, title of document/report and URL. If this information is not available, the reference should be removed and only the web address cited in the text. Smith A Select committee report into social care in the community [WWW document]. (1999) URL http://www.dhss.gov.uk/reports/report015285. html [accessed on 7 November 2003].

Tables, Figures and Figure Legends

Tables should be submitted as word format, numbered and cited in the text of the manuscript. Units of measurements must be included in the column title or in the figure legend or caption. Figure files accepted: TIF, EPS, JPEG.

  • color (saved as CMYK): minimum 300 dpi;
  • black and white/grays: minimum 600 dpi;
  • one column width (8.0 cm) or 1.5 column widths (13.0 cm) or 2 columns widths (17.0 cm).

A different caption for each figure must be provided at the end of the manuscript, not included in the figure file. Authors must obtain written permission for the reproduction and adaptation of material which has already been published. A copy of the written permission has to be provided before publication (otherwise the paper cannot be published) and appropriately cited in the figure caption. The procedure for requesting the permission is the responsibility of the Authors; PAGEPress will not refund any costs incurred in obtaining permission. Alternatively, it is advisable to use materials from other (free) sources. Figure legends should begin with a brief title for the whole figure and continue with a short description of each panel and the symbols used; they should not contain any details of methods.

Peer-review policy

All manuscripts submitted to our journal are critically assessed by external and/or in-house experts in accordance with the principles of peer review (http://www.icmje.org/#peer), which is fundamental to the scientific publication process and the dissemination of sound science. Each paper is first assigned by the Editors to an appropriate Associate Editor who has knowledge of the field discussed in the manuscript. The first step of manuscript selection takes place entirely in-house and has two major objectives: i) to establish the article appropriateness for our journals readership; ii) to define the manuscript priority ranking relative to other manuscripts under consideration, since the number of papers that the journal receives is much greater than it can publish. If a manuscript does not receive a sufficiently high priority score to warrant publication, the editors will proceed to a quick rejection. The remaining articles are reviewed by at least two different external referees (second step or classical peer review). Manuscripts should be prepared according to the Uniform Requirements established by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/#prepare).

Authorship
All persons designated as authors should qualify for authorship according to the ICMJE criteria (http://www.icmje.org/ethical_1author.html). Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should only be based on substantial contributions to i) conception and design, or analysis and interpretation of data; and to ii) drafting the article or revising it critically for important intellectual content; and on iii) final approval of the version to be published. These three conditions must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Authors should provide a brief description of their individual contributions.

Obligation to Register Clinical Trials (http://www.icmje.org/#clin_trials)
The ICMJE believes that it is important to foster a comprehensive, publicly available database of clinical trials. The ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, etc. Our journals require, as a condition of consideration for publication, registration in a public trials registry. The journal considers a trial for publication only if it has been registered before the enrollment of the first patient. The journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a non-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include a minimum of data elements (http://www.icmje.org/#clin_trials). For example, ClinicalTrials.gov (http://www.clinicaltrials.gov), sponsored by the United States National Library of Medicine, meets these requirements.

Protection of Human Subjects and Animals in Research
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013 (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the World Medical Association (2016 revision, https://www.wma.net/policies-post/wma-statement-on-animal-use-in-biomedical-research) and from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare (http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors). When reporting experiments on ecosystems involving non-native species, Authors are bound to ensure compliance with the institutional and national guide for the preservation of native biodiversity.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor it is under submission to another journal for consideration (or an explanation should be provided in Comments to the Editor).
  • We fight plagiarism: please understand that your article will be checked with available tools for discovering plagiarism.
  • The submission file is in OpenOffice, Microsoft Word or RTF document file format.
  • Where available, URLs for the references should be provided.
  • Every illustrations, figure and table has its own caption: they are placed within the text at the appropriate points, rather than at the end: please read Guidelines for Authors for detailed information.
  • The text adheres to the stylistic and bibliographic requirements outlined in About the Journal.
  • Please read this advice and download associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new “Disclosure Form for Potential Conflict of Interest”, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editors’ requests. We at PAGEPress Publications welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the “Uniform Format for Disclosure of Competing Interests in ICMJE Journals” and upload it on the Web site of the PAGEPress journal your work is involved with or email it back to us, in mind to allow PAGEPress to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly. Kindly note that the format have to be completed and signed by each author of the work. We remain waiting for the completed form to proceed with publication. Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.

Privacy Statement

Introduction

In accordance with European Union guidelines General Data Protection Regulation (GDPR), users may decline to provide the information requested. They should be advised, however, that PAGEPress may be unable to deliver its services unless at least the information necessary for security and identification purposes is provided. In order to offer the best possible service to users, we  tracks the patterns of usage of pages on our sites. This enables us to identify the most popular articles and services. Where users have provided details of their research areas of interest, this information can be correlated, helping PAGEPress to provide a useful service for scientists, offering them the most relevant information based on their areas of interest. User information will only be shared with third parties with the explicit consent of the user.  
Publishing a scientific manuscript is inherently a public (as opposed to anonymous) process. The name and e-mail address of all authors of a manuscript published and/or submitted will be available to users of PAGEPress. These details are made available in this way purely to facilitate scientific communication. Collecting these e-mail addresses for commercial use is not allowed, nor will PAGEPress itself send unsolicited e-mail to authors, unless it directly concerns the paper they have published on any PAGEPress journals.
We will only use the personal data gathered over this website as set out in this policy. Below you will find information on how we use your personal data, for which purposes your personal data is used, with whom it is shared and what control and information rights you may have.

Protecting users' personal information
Our journals’ sites use cookies to help provide you with the best viewing experience: some aspects of our services published on our website do require the use of cookies, and the supply of information such as name, e-mail address etc. This is necessary for security reasons and also for us to be able to assure standards of scientific integrity. Users may submit further personal information (e.g. details of research areas of interest) in order to take advantage of present and future personalization facilities on our website.
PAGEPress Publications process personal data from our members, participants, grantees and other contact persons, in order to provide our services in the best way possible. This statement explains how and why we are processing personal data. This privacy statement relates to all our processes involving personal data.

Our processing activities
We publish scholarly journals, proceedings, news and data. This material is freely available. The following summary offers a quick overview of the data processing activities that are undertaken on our website. You will find more detailed information under the indicated sections below.

  • When you visit our website for informational reasons without setting up an account, only limited personal data will be processed to provide you with the website itself.
  • If you are identified as belonging to a customer organisation then we collect information in order to be able to provide usage reporting to that customer.
  • In case you register for one our services or subscribe to our article alerts or newsletters, further personal data will be processed in the scope of such services.
  • Furthermore, your personal data will be used to provide you with relevant advertising for our services and products and for statistical analysis that helps us to improve our website. Additionally, we improve your website experience with third party content.
  • Your personal data may be disclosed to third parties that might be located outside your country of residence; potentially, different data protection standards may apply.
  • We have implemented appropriate safeguards to secure your personal data and retain your personal data only as long as necessary.
  • Under the legislation applicable to you, you may be entitled to exercise certain rights with regard to the processing of your personal data.

Definitions
Personal data: means any information relating to a natural person who can be identified, directly or indirectly, in particular by reference to an identifier such as a name, an identification number, location data, or an online identifier.
Processing: means any operation which is performed on personal data, such as collection, recording, organisation, structuring,storage, adaptation or any kind of disclosure or other use.

Informational use of the website
When you visit our website for informational reasons, i.e. without registering for any of our provided services and without providing us with personal data in any other form, we may automatically collect additional information about you which will contain personal data only in limited cases and which is automatically recognised by our server, such as:

  • your IP address
  • your device type, name and IDs
  • the date and time of your requests
  • the content of your requests
  • information on your browser version
  • your screen resolution
  • information on your operating system, including language settings.

We use such information only to assist us in providing an effective service (e.g. to adapt our website to the needs of your device or to allow you to log in to our website), and to collect broad demographic information for anonymized, aggregated use.

If you are identified by IP or equivalent method as belonging to a customer organisation such as university or a company then we will also collect the identity of that organisation and use it to create usage reports which show the organisation how much of the content we publish is being read by their students, members or employees. This information does not contain anything related to a personal login unless (a) you are a nominated administrator for that organisation or (b) your organisation specifically requires it as a part of a usage-based access contract.
The personal data automatically collected is necessary for us to provide the website, and for our legitimate interest to guarantee the website's stability and security.

Registration for our services
If you need to create a personal login with us then we will store and process the following:

  • Information (such as your name, user name and email address) that is provided by registration
  • Information in connection with an account sign-in facility (e.g. log-in and password details)
  • Communications sent by you (e.g. via e-mail or website communication forms)
  • The information that is necessary for the performance of the service is labelled accordingly. All further information is provided voluntarily.

We will process the personal data you provide to:

  • Identify you at sign-in
  • Provide you with the services and information offered through the website or which you request
  • Administer your account
  • Communicate with you
  • Behavioural Advertising and profiling

You can object to the use of your personal data for direct marketing at any time. We will then refrain from any processing to the extent it is related to such purposes. You may opt-out of direct marketing via opt-out links in any marketing communication or via user profile pages on the website (where available). You can also inform us about your objection by contacting our Data Protection Office at privacy@pagepress.org

We offer notification services such as table-of-contents or new article alerts. This service is provided by means of a double-opt-in. Thus, you will receive an email containing a link by which you can confirm that you are the owner of the email address and wish to be notified via our email service. You can end this service by opting out via the link provided in each notification email. This notification service is based on your consent.
Registration data is kept until such time as an account deletion request is made. If such a request is received we will erase your data within 60 days. Statutory storage obligations or the need for legal actions that may arise from misconduct within the services or payment problems can lead to a longer retention of your personal data. In this case, we will inform you accordingly.

Alerts and Newsletters
With your email address you can subscribe to article alerts and newsletters that provides you with the latest news about our products and services if you consent to receiving such alerts and newsletters. Your email address will be retained as long as you subscribe to our alerts and newsletters.
This service is provided by means of a double-opt-in. Thus, you will receive an email containing a link by which you can confirm that you are the owner of the email address and wish to be notified via our email service. When your subscription is not confirmed, the personal data you provided will not be processed for any purpose. You can unsubscribe from this service by opting out via the link provided in each newsletter.

Analytics

For statistical analyses we use web analytics services such as Google Analytics to collect information about the use of this site.
General tracking information
The tools collect information such as

  • Device and browser information (operating system information, Mobile device identifier, mobile operating system, etc.)
  • IP address
  • Page accessed, URL click stream (the chronological order of our internet sites you visited)
  • Geographic location
  • Time of visit
  • Referring site, application, or service

We use the information we get from the providers only to determine the most useful information you are looking for, and to improve and optimise this website. We do not combine the information collected through the use of the tools with personal data.
Depending on the provider the information generated about your use of the website may be transferred to and processed in third countries, e.g. the United States. For further information about the potential risks of a cross border data transfer please refer to section XII. The tools collect only the IP address assigned to you on the date you visit this site, rather than your name or any other identifying information. The provider will use this information in order to evaluate your use of the website, to compile reports on website activities and to provide other services relating to website and internet use to us.
The legal basis for this processing is Art. 6 sec. 1 sent. 1 lit. f GDPR and represents our legitimate interest to analyse our website's traffic to improve the user's experience and to optimise the website in general.

Google Analytics / Google Tag Manager

We use Google Analytics, a web analytics service provided by Google LLC, 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA ("Google"). On our behalf Google will use the information generated by a cookie for the purpose of evaluating your use of the website, compiling reports on website activity and providing other services relating to website activity and internet activity in connection with the use of the website.
We have activated the IP-anonymisation within the Google Analytics service, and your IP address will be truncated within the area of member states of the European Union or other parties to the Agreement on the European Economic Area. Only in exceptional cases the whole IP address will be first transferred to a Google server in the USA and truncated there. The IP-address your browser conveys within the scope of Google Analytics will not be associated with any other data held by Google.
You may refuse the use of cookies by selecting the appropriate settings on your browser; however please note that if you do this you may not be able to use the full functionality of this website. In addition to that you may prevent the collection of the information generated by the cookie about your use of the website (including you IP address) and the processing of this data by Google if you download and install the browser plug-in available at the following link: http://tools.google.com/dlpage/gaoptout

Third party content and social media plug-ins
Links to third party websites
This website may contain links to third party websites. We are not responsible for the content and the data collection on respective third party websites; please check the privacy policy of respective websites for information of respective websites' data processing activities.

Information sharing
Where personal data is disclosed to the following third parties for the purposes mentioned above the legal basis for the transfer of your personal data is Article 6 sec. 1 sent. 1 lit. b and f GDPR. Some of the recipients may reside outside the EEA. For further information about cross border transfer in general and transfers outside of the EEA see XII.
We may disclose anonymous aggregate statistics about users of the website in order to describe our services to prospective partners, advertisers and other reputable third parties and for other lawful purposes, but these statistics will include no personal data.
We may disclose your personal data to contractors who assist us in providing the services we offer through the website. Such a transfer will be based on data processing agreements. Therefore, our contractors will only use your personal data to the extent necessary to perform their functions and will be contractually bound to process your personal data only on our behalf and in compliance with our requests.
In the event that we undergo re-organisation or are sold to a third party, any personal data we hold about you may be transferred to that re-organised entity or third party in compliance with applicable law.
We may disclose your personal data if legally entitled or required to do so (for example if required by law or by a court order).

Cross border data transfers
Within the scope of our information sharing activities set out above, your personal data may be transferred to other countries (including countries outside the EU) which may have different data protection standards from your country of residence. Please note that data processed in a foreign country may be subject to foreign laws and accessible to foreign governments, courts, law enforcement, and regulatory agencies. However, we will endeavour to take reasonable measures to maintain an adequate level of data protection when sharing your personal data with such countries.
In the case of a transfer outside of the EU, this transfer is safeguarded by privacy the Privacy Shield and EU Model Clauses. You can find further information about the aforementioned safeguards by following this link https://ec.europa.eu/info/law/law-topic/data-protection_en

Security
We have reasonable state of the art security measures in place to protect against the loss, misuse and alteration of personal data under our control. For example, our security and privacy policies are periodically reviewed and enhanced as necessary and only authorised personnel have access to personal data. Whilst we cannot ensure or guarantee that loss, misuse or alteration of information will never occur, we use all reasonable efforts to prevent it.
You should bear in mind that submission of information over the internet is never entirely secure. We cannot guarantee the security of information you submit via our website whilst it is in transit over the internet and any such submission is at your own risk.

Data retention
We strive to keep our processing activities with respect to your personal data as limited as possible. In the absence of specific retention periods set out in this policy, your personal data will be retained only for as long as we need it to fulfil the purpose for which we have collected it and, if applicable, as long as required by statutory retention requirements.

Your rights
Under the legislation applicable to you, you may be entitled to exercise some or all of the following rights:

  1. require (i) information as to whether your personal data is retained and (ii) access to and/or duplicates of your personal data retained, including the purposes of the processing, the categories of personal data concerned, and the data recipients as well as potential retention period;
  2. request rectification, removal or restriction of your personal data, e.g. because (i) it is incomplete or inaccurate, (ii) it is no longer needed for the purposes for which it was collected, or (iii) the consent on which the processing was based has been withdrawn;
  3. refuse to provide and -- without impact to data processing activities that have taken place before such withdrawal -- withdraw your consent to processing of your personal data at any time;
  4. object, on grounds relating to your particular situation, that your personal data shall be subject to a processing. In this case, please provide us with information about your particular situation. After the assessment of the facts presented by you we will either stop processing your personal data or present you our compelling legitimate grounds for an ongoing processing;
  5. take legal actions in relation to any potential breach of your rights regarding the processing of your personal data, as well as to lodge complaints before the competent data protection regulators;
  6. require (i) to receive the personal data concerning you, which you have provided to us, in a structured, commonly used and machine-readable format and (ii) to transmit those data to another controller without hindrance from our side; where technically feasible you shall have the right to have the personal data transmitted directly from us to another controller; and/or
  7. not to be subject to any automated decision making, including profiling (automatic decisions based on data processing by automatic means, for the purpose of assessing several personal aspects) which produce legal effects on you or affects you with similar significance.

You may (i) exercise the rights referred to above or (ii) pose any questions or (iii) make any complaints regarding our data processing by contacting us using the contact details set out below.

Amendments to this policy
We reserve the right to change this policy from time to time by updating our website respectively. Please visit the website regularly and check our respective current privacy policy. This policy was last updated on 16/05/2018.
For any questions on how we protect your personal data, you can always contact us by e-mail privacy@pagepress.org

The Italian version of this document is available here.